Air purification for medical environments Air purification for medical environments

Molekule air purification for medical environments

U.S. Food and Drug Administration (FDA) has cleared the 510(k) premarket notification for Molekule’s new commercial air purifier, Molekule Air Pro RX

Molekule Air Pro RX is intended for medical purposes to destroy bacteria and viruses in the air and is well-suited for use in operating rooms, emergency departments, waiting rooms, isolation units, and any critical or high-traffic area in healthcare facilities to provide additional frontline protection.

For use during public health emergency to help destroy airborne SARS-CoV-2, the virus causing COVID-19

Molekule’s proprietary PECO air purification technology destroys a wide range of pollutants including viruses, mold, bacteria, and other harmful chemicals in the air. Our technology represents a vastly different approach than standard HEPA air filters currently on the market—and currently used in medical settings. The United States Food and Drug Administration (FDA) recently published guidance related to air purifiers and potential effectiveness relating to SARS-CoV-2.  Molekule’s PECO technology, incorporated into its Air, Air Mini, and Air Pro RX devices, has been tested and satisfies the performance elements outlined in the FDA guidance.

Molekule's air purification technology provided a greater than 4-log reduction of a virus proxy of SARS-CoV-2, the coronavirus that causes COVID-19. 

As a result, Molekule’s devices may be sold during the current health emergency for the intended use of destroying SARS-CoV-2 in medical and healthcare facilities. Our devices are not intended to replace personal protective equipment or other similar medical countermeasures to SARS-CoV-2. See our full labeling instructions here, which includes detailed information on device usage, potential risks, and instructions for cleaning and safe disposal of device filters.

To purchase devices for medical or healthcare facilities, please fill out a purchase form.

Molekule air purification for medical environments

U.S. Food and Drug Administration (FDA) has cleared the 510(k) premarket notification for Molekule’s new commercial air purifier, Molekule Air Pro RX

Molekule Air Pro RX is intended for medical purposes to destroy bacteria and viruses in the air and is well-suited for use in operating rooms, emergency departments, waiting rooms, isolation units, and any critical or high-traffic area in healthcare facilities to provide additional frontline protection.

For use during public health emergency to help destroy airborne SARS-CoV-2, the virus causing COVID-19

Molekule’s proprietary PECO air purification technology destroys a wide range of pollutants including viruses, mold, bacteria, and other harmful chemicals in the air. Our technology represents a vastly different approach than standard HEPA air filters currently on the market—and currently used in medical settings. The United States Food and Drug Administration (FDA) recently published guidance related to air purifiers and potential effectiveness relating to SARS-CoV-2.  Molekule’s PECO technology, incorporated into its Air, Air Mini, and Air Pro RX devices, has been tested and satisfies the performance elements outlined in the FDA guidance.

Molekule's air purification technology provided a greater than 4-log reduction of a virus proxy of SARS-CoV-2, the coronavirus that causes COVID-19. 

As a result, Molekule’s devices may be sold during the current health emergency for the intended use of destroying SARS-CoV-2 in medical and healthcare facilities. Our devices are not intended to replace personal protective equipment or other similar medical countermeasures to SARS-CoV-2. See our full labeling instructions here, which includes detailed information on device usage, potential risks, and instructions for cleaning and safe disposal of device filters.

To purchase devices for medical or healthcare facilities, please fill out a purchase form.

Testing shows PECO destroys airborne viruses 

Molekule’s PECO technology destroys viruses, like RNA and DNA viruses MS2 and Phi X 174, which can travel in tiny aggregated droplets that can linger for hours before settling on surfaces.  

MS2 virus reduction report >

Phi X 174 reduction report >

MS2 virus & Phi X 174 destruction report >

Molekule Air Pro RX

Designed for use in medical and healthcare facilities to destroy airborne viruses. Ideal for use in critical environments and high-traffic areas greater than 600 sq. ft., such as emergency departments, operating rooms, intensive care units, and waiting rooms.

See purchase form >

Molekule Air

Designed for rooms up to 600 sq. ft. and high-traffic medical and healthcare facilities to destroy airborne viruses.

See purchase form >

Molekule Air Mini

Designed for rooms up to 250 sq. ft. like on-call rooms and high-traffic areas to destroy airborne viruses.

See purchase form >

Greater than 4-log destruction for tested bioaerosols

Testing was completed at ARE Labs using swatch testing on a prototype PECO-Filter using the same core catalyst technology in our current products. All testing was completed in triplicate and followed EPA Good Laboratory Practices as defined in 40 CFR, Part 160.

Supplemental instructions

When used in medical or healthcare facilities pursuant to FDA Enforcement Policy for Sterilizers, Disinfectant Devices, and Air Purifiers during the Coronavirus Disease 2019 (COVID-19) Public Health Emergency, please follow these supplemental instructions.

Download full text >

Supplemental instructions

When used in medical or healthcare facilities pursuant to FDA Enforcement Policy for Sterilizers, Disinfectant Devices, and Air Purifiers during the Coronavirus Disease 2019 (COVID-19) Public Health Emergency, please follow these supplemental instructions.

Download full text >

Air purification for medical environments Air purification for medical environments